CAS 2697127-16-3
:Formula:C26H31NO
InChI:InChI=1S/C26H31NO/c1-17(28)18-10-12-25(2)20(15-18)6-7-21-23-9-8-22(19-5-4-14-27-16-19)26(23,3)13-11-24(21)25/h4-6,8,14-16,21,23-24H,7,9-13H2,1-3H3/t21-,23-,24-,25-,26+/m0/s1
InChI key:OEPAMUSCEIIABQ-YZUYXXDVSA-N
SMILES:CC(=O)C1=CC2=CC[C@@H]3[C@@H]([C@]2(CC1)C)CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 6 prodotti.
3-Deoxy-3-acetyl Abiraterone-3-ene (1-((8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl)ethan-1-one)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C26H31NOColore e forma:White Off-White PowderPeso molecolare:373.24056Abiraterone Impurity 13 (3-Deoxy-3-Acetyl Abiraterone-3-Ene)
CAS:Formula:C26H31NOColore e forma:Yellow SolidPeso molecolare:373.543-Deoxy-3-acetylabiraterone-3-ene
CAS:Prodotto controllatoApplications 3-Deoxy-3-acetylabiraterone-3-ene is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
References Denis, L., et al.: Cancer, 72, 3888 (1993); Potter, G.A., et al.: J. Med. Chem., 38, 2463 (1995); Denmeade, S., et al.: Nat. Rev., 2, 389(2002); Scher, H., et al.: J. Clin. Oncol., 23, 8253 (2005)Formula:C26H31NOColore e forma:NeatPeso molecolare:373.533-Deoxy-3-acetylabiraterone-4,6-ene
CAS:Prodotto controllatoFormula:C26H31NOColore e forma:NeatPeso molecolare:373.53Ref: ST-EA-CP-A67007
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta3-Deoxy-3-acetylabiraterone-3-ene
CAS:Prodotto controllatoPlease enquire for more information about 3-Deoxy-3-acetylabiraterone-3-ene including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C23H31NOPurezza:Min. 95%Colore e forma:PowderPeso molecolare:373.53 g/mol
